RECELL® System

RECELL uses a small piece of the patient’s skin to create a multi-phenotype suspension of Spray-On Skin Cells.

The application of different cell types stimulates healing and regimentation throughout the wound bed as opposed to solely relying on healing from the wound edges for definitive closure.

Autologous cell therapy at the point-of-care allows for delivery of the patient’s own cells.

CONTACT US FOR INFORMATION
Clinical Studies

Author

Title

James Hill Holmes IV, MD, Joseph A. Molnar, MD, PhD, Jeffrey E. Carter, MD, James Hwang, MD, Bruce A. Cairns, MD, Booker T. King, MD, David J. Smith, MD, C. Wayne Cruse, MD, Kevin N. Foster, MD, Michael D. Peck, MD, Rajiv Sood, MD, Michael J. Feldman, MD, Marion H. Jordan, MD, David W. Mozingo, MD, David G. Greenhalgh, MD, Tina L. Palmieri, MD, John A. Griswold, MD, Sharmila Dissanaike, MD, William L. Hickerson, MD

A Comparative Study of the ReCell® Device and Autologous Split-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries

J.H. Holmes IV, J.A. Molnar, J.W. Shupp, W.L. Hickerson, B.T. King, K.N. Foster, B.A. Cairns, J.E. Carter

Demonstration of the safety and effectiveness of the RECELL1 System combined with split-thickness meshed autografts for the reduction of donor skin to treat mixed-depth burn injuries

Sharon Henry, MD, Steven Mapula, MD, Mark Grevious, MD, Kevin N. Foster, MD, Herbert Phelan, MD, Jeffrey Shupp, MD, Rodney Chan, MD, David Harrington, MD, Neil Mashruwala, MD, David A. Brown, MD, PhD, Haaris Mir, MD, George Singer, MD, Alfredo Cordova, MD, Lisa Rae, MD, Theresa Chin, MD, Lourdes Castanon, MD, Derek Bell, MD, William Hughes, MD, Joseph A. Molnar, MD

Maximizing wound coverage in full-thickness skin defects: A randomized-controlled trial of autologous skin cell suspension and widely meshed autograft versus standard autografting

For any product information or to order, please get in touch

Get In Touch